top of page

Align Summit 2026: Unravel Biosciences spun out of Harvard's Wyss Institute and is using AI to analyze patient RNA samples to find existing compounds that can make a difference in rare disease

3 hours ago
1 min read

Co-Founder & CEO Richard Novak describes the screening process and the benefits of focusing on existing compounds for which the profile is already largely known. The lead program is already in the clinic for Rett syndrome and Pitt Hopkins syndrome.




Coverage brought to you by



Join the BiotechTV mailing list

Thanks for subscribing!

Follow BiotechTV

  • Twitter

@BiotechTV

  • LinkedIn

BiotechTV

  • Facebook

BiotechTVHQ

  • TikTok

@BiotechTV

  • Instagram

@BiotechTVHQ

Also look for unique social pages for BiotechTV U.

Sponsor Spotlight

10x_Genomics_logo.svg.png

10x Genomics delivers powerful, reliable tools that fuel scientific discoveries and drive exponential progress to master biology to advance human health. Cited in more than 10,000 research papers, our innovative single cell, spatial, and in situ technologies enable discoveries across oncology, immunology, neuroscience, and more.

 

Our talented, dedicated science professionals have a distinguished record of creating innovative instruments, reagents, and software that analyze biological systems at a resolution that matches the complexity of biology.

Learn more

bottom of page